Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival - Concepedia

Concepedia

Publication | Closed Access

Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival

57

Citations

24

References

2013

Year

Andrea Lo, William Morris, Vincent Lapointe, Jeremy Hamm, Mira Keyes, Tom Pickles, Michael McKenzie, Ingrid Spadinger

International Journal of Radiation Oncology*Biology*Physics

UrologyGenitourinary CancerMedicineBrachytherapyDisease-free SurvivalLow-dose-rate Prostate BrachytherapyProstatic DiseaseOncologyRadiation OncologyProstate-specific Antigen

References

	Year	Citations

Page 1

Page 1